Financial Statements
2022
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2022 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2022 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2021 |
|
|
||
2021
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2021 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2021 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2021 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2020 |
|
|
||
2020
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2020 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2020 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2020 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2019 |
|
|
||
2019
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2019 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2019 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2019 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2018 |
|
|
||
2018
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2018 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2018 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2018 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2017 |
|
|
||
2017
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2017 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2017 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2017 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2016 |
|
|
||
2016
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2016 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2016 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2016 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2015 |
2015
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2015 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2015 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2015 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2014 |
2014
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2014 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2014 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2014 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2013 |
2013
| 4th Quarter | Consolidated financial statements and MD&A for the period ended | September 30, 2013 |
|
|
||
| 3rd Quarter | Consolidated financial statements and MD&A for the period ended | June 30, 2013 |
|
|
||
| 2nd Quarter | Consolidated financial statements and MD&A for the period ended | March 31, 2013 |
|
|
||
| 1st Quarter | Consolidated financial statements and MD&A for the period ended | December 31, 2012 |